CBSTF: AI 评分 42/100 — AI 分析 (4月 2026)

The Cannabist Company Holdings Inc. cultivates, manufactures, and provides cannabis products and related services across the United States and internationally. They offer a range of cannabis products, holding licenses in 17 jurisdictions within the U.S.

Key Facts: AI Score: 42/100 Sector: Healthcare

公司概况

概要：

The Cannabist Company Holdings Inc. operates in the cannabis industry, cultivating, manufacturing, and distributing a variety of cannabis products. With licenses in 17 U.S. jurisdictions, the company offers flower, edibles, oils, and tablets under multiple brands, positioning itself in the competitive and evolving cannabis market.

CBSTF是做什么的？

The Cannabist Company Holdings Inc., formerly known as Columbia Care Inc., was founded in 2012 and rebranded in September 2023. Headquartered in New York City, the company operates in the cannabis industry, focusing on the cultivation, manufacturing, and distribution of cannabis products and related services. The company's product offerings include flower, edibles, oils, and tablets, marketed under brand names such as Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. The Cannabist Company holds licenses in 17 jurisdictions within the United States, allowing it to operate across multiple states. This multi-state presence is crucial in the fragmented legal landscape of the cannabis industry in the U.S. The company aims to cater to a broad spectrum of consumer preferences through its diverse product portfolio. By offering a range of consumption methods and product types, The Cannabist Company seeks to capture different segments of the cannabis market. The company's strategic focus includes expanding its brand presence and optimizing its operational efficiency within existing markets. The Cannabist Company navigates the complex regulatory environment of the cannabis industry to establish a strong foothold in key markets.

CBSTF的投资论点是什么？

The Cannabist Company Holdings Inc. presents a speculative investment opportunity within the evolving cannabis industry. The company's multi-state presence, with licenses in 17 jurisdictions, provides a foundation for growth as legalization expands. However, the company's negative P/E ratio of -0.07 and a negative profit margin of -51.2% indicate significant financial challenges. The gross margin of 29.5% suggests potential for improvement through operational efficiencies and strategic pricing. Key catalysts include potential regulatory changes and expansion into new markets. Investors should closely monitor the company's ability to achieve profitability and manage its operational costs. The company's beta of 0.75 suggests lower volatility compared to the overall market.

CBSTF在哪个行业运营？

The Cannabist Company operates within the rapidly evolving cannabis industry, which is characterized by increasing legalization and market expansion. The U.S. cannabis market is projected to reach significant growth in the coming years, driven by both medical and recreational use. The competitive landscape includes both large multi-state operators and smaller regional players. Companies like CANSF (Columbia Care Cannabis Corp), CNTMF (Cresco Labs Inc.), DXBRF (Dixie Brands Inc.), ELIXF (Elixinol Wellness Limited), and GHBWF (Greenlane Holdings Inc.) represent key competitors, each vying for market share through different strategies, such as brand differentiation, geographic expansion, and product innovation. The industry faces regulatory hurdles and varying state laws, requiring companies to navigate a complex legal environment.

Drug Manufacturers - Specialty & Generic

Healthcare

CBSTF有哪些增长机遇？

Expansion into New Markets: As cannabis legalization continues to spread across the United States and internationally, The Cannabist Company has the opportunity to expand its operations into new markets. Each new state or country that legalizes cannabis represents a potential revenue stream and growth opportunity. The timeline for this growth is dependent on the pace of legalization efforts, but the long-term trend is toward greater acceptance and accessibility. The company's existing licenses in 17 U.S. jurisdictions provide a strong foundation for further expansion.
Product Innovation and Diversification: The Cannabist Company can drive growth by innovating and diversifying its product offerings. This includes developing new cannabis-infused products, exploring different consumption methods, and catering to specific consumer preferences. The market for cannabis-infused beverages, edibles, and wellness products is growing rapidly, presenting opportunities for the company to capture new market segments. The timeline for product development and launch is relatively short, allowing the company to quickly adapt to changing consumer demands.
Strategic Partnerships and Acquisitions: The Cannabist Company can accelerate its growth through strategic partnerships and acquisitions. Collaborating with other companies in the cannabis industry, such as technology providers, distribution networks, or retail operators, can enhance its operational capabilities and market reach. Acquiring smaller companies with complementary products or technologies can also drive growth and expand its market share. The timeline for partnerships and acquisitions varies depending on the specific opportunities, but these strategies can provide significant growth potential in the medium to long term.
Brand Building and Marketing: Investing in brand building and marketing is crucial for The Cannabist Company to differentiate itself from competitors and attract new customers. Developing strong brand recognition and loyalty can drive sales and increase market share. This includes creating compelling marketing campaigns, engaging with consumers through social media, and sponsoring events. The timeline for brand building is ongoing, requiring consistent effort and investment over the long term. A strong brand can command premium pricing and create a sustainable competitive advantage.
Operational Efficiency and Cost Optimization: Improving operational efficiency and optimizing costs can significantly enhance The Cannabist Company's profitability and competitiveness. This includes streamlining its cultivation and manufacturing processes, reducing waste, and optimizing its supply chain. Implementing technology solutions, such as automation and data analytics, can also drive efficiency and reduce costs. The timeline for operational improvements is ongoing, requiring continuous monitoring and optimization. Increased efficiency can lead to higher gross margins and improved financial performance.

Market capitalization of $0.01 billion indicates a small-cap company with potential for growth but also higher risk.
Negative P/E ratio of -0.07 reflects current unprofitability, requiring careful monitoring of future earnings potential.
Profit margin of -51.2% highlights significant operational challenges and the need for improved cost management.
Gross margin of 29.5% suggests potential for profitability if operational efficiencies are improved.
Licenses in 17 U.S. jurisdictions provide a substantial footprint for expansion as cannabis legalization progresses.

CBSTF提供哪些产品和服务？

Cultivates cannabis plants in licensed facilities.
Manufactures a variety of cannabis products, including flower, edibles, oils, and tablets.
Distributes cannabis products through its own retail locations and wholesale channels.
Markets its products under various brand names, such as Seed & Strain, Triple Seven, and Hedy.
Holds licenses to operate in 17 jurisdictions in the United States.
Provides cannabis-related services to consumers and businesses.

CBSTF如何赚钱？

Cultivation and Manufacturing: The company grows cannabis and manufactures various cannabis products.
Retail Sales: The company sells its products directly to consumers through its own retail stores.
Wholesale Distribution: The company distributes its products to other retailers and dispensaries.

Adult recreational cannabis users.
Patients with medical cannabis prescriptions.
Wholesale clients, including other dispensaries and retailers.

Licenses: Holding licenses in 17 U.S. jurisdictions creates a barrier to entry.
Brand Portfolio: A diverse portfolio of brands caters to different consumer segments.
Vertical Integration: Controlling the cultivation, manufacturing, and distribution processes provides greater control over the supply chain and product quality.

什么因素可能推动CBSTF股价上涨？

Ongoing: Expansion into new markets as cannabis legalization progresses.
Ongoing: Product innovation and diversification to meet evolving consumer preferences.
Upcoming: Potential regulatory changes at the state or federal level.
Ongoing: Strategic partnerships and acquisitions to expand market reach.
Ongoing: Efforts to improve operational efficiency and reduce costs.

CBSTF的主要风险是什么？

Ongoing: Intense competition from other cannabis companies.
Ongoing: Regulatory uncertainty and changing laws.
Potential: Fluctuations in cannabis prices.
Potential: Negative public perception of cannabis.
Ongoing: Limited access to capital due to the nature of the business.

CBSTF的核心优势是什么？

Licenses in 17 U.S. jurisdictions.
Diverse product portfolio.
Established brand names.
Vertical integration.

CBSTF的劣势是什么？

Negative profit margin.
High operational costs.
Limited brand recognition compared to larger competitors.
Dependence on regulatory changes.

CBSTF有哪些机遇？

Expansion into new markets as legalization progresses.
Product innovation and diversification.
Strategic partnerships and acquisitions.
Increasing demand for cannabis products.

CBSTF面临哪些威胁？

Intense competition.
Regulatory uncertainty.
Fluctuations in cannabis prices.
Negative public perception of cannabis.

CBSTF的竞争对手是谁？

Columbia Care Cannabis Corp — Multi-state operator with a focus on medical cannabis. — (CANSF)
Cresco Labs Inc. — Known for its branded products and retail footprint. — (CNTMF)
Dixie Brands Inc. — Focuses on cannabis-infused products. — (DXBRF)
Elixinol Wellness Limited — Specializes in hemp-derived CBD products. — (ELIXF)
Greenlane Holdings Inc. — Distributes cannabis accessories and hardware. — (GHBWF)

Key Metrics

MoonshotScore: 42/100

Company Profile

CEO: David J. Hart
Headquarters: New York City, US
Employees: 1,681
Founded: 2019

AI Insight

AI analysis pending for CBSTF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does The Cannabist Company Holdings Inc. do?

The Cannabist Company Holdings Inc. cultivates, manufactures, and distributes a range of cannabis products, including flower, edibles, oils, and tablets, under various brand names. They operate in 17 U.S. jurisdictions, navigating the complex regulatory landscape of the cannabis industry. The company aims to cater to both recreational and medical cannabis users through its diverse product portfolio and multi-state presence. Their business model encompasses cultivation, manufacturing, retail sales, and wholesale distribution, positioning them as a vertically integrated player in the cannabis market.

What do analysts say about CBSTF stock?

As of 2026-03-17, formal analyst ratings for CBSTF are unavailable, likely due to its OTC listing and small market capitalization. Investors should focus on fundamental analysis, monitoring revenue growth, gross margins, and progress toward profitability. Key valuation metrics to consider include price-to-sales ratio and enterprise value-to-EBITDA, compared to peers. Growth considerations involve expansion into new markets, product innovation, and the evolving regulatory landscape. Due to the speculative nature of the stock, investors should conduct thorough due diligence and assess their risk tolerance.

What are the main risks for CBSTF?

The Cannabist Company faces several key risks, including intense competition in the cannabis industry, regulatory uncertainty, and fluctuations in cannabis prices. The company's negative profit margin and high operational costs pose significant financial challenges. As an OTC-listed company, CBSTF is subject to less stringent regulatory oversight and faces liquidity risks. Dependence on regulatory changes and potential negative public perception of cannabis also present ongoing risks. Investors should carefully consider these factors before investing.

What revenue streams does The Cannabist Company Holdings Inc. have in healthcare?

The Cannabist Company Holdings Inc. generates revenue through the sale of cannabis products, including flower, edibles, oils, and tablets, to both medical and recreational users. The company's revenue streams are geographically diversified across the 17 U.S. jurisdictions where it holds licenses. While specific revenue breakdowns by product line and therapeutic area are not available, the company's focus on both medical and recreational markets provides multiple avenues for revenue generation. The company's ability to expand its product offerings and market reach will be crucial for driving future revenue growth.

How does The Cannabist Company Holdings Inc. compete with larger cannabis companies?

The Cannabist Company Holdings Inc. competes with larger cannabis companies through a combination of strategic differentiation and operational focus. While lacking the scale and resources of larger multi-state operators, The Cannabist Company leverages its established brand names, diverse product portfolio, and licenses in key markets to carve out a competitive niche. The company focuses on product innovation, catering to specific consumer preferences, and building strong brand loyalty. Strategic partnerships and acquisitions can also enhance its competitive position. By optimizing its operational efficiency and cost structure, The Cannabist Company aims to compete effectively within the evolving cannabis landscape.